Related Experiment Video
Updated: Feb 23, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Increased monocyte-to-HDL cholesterol ratio is related to cardiac syndrome X
Adnan Dogan1, Muhammed Oylumlu1
1a Department of Cardiology , Dumlupinar University School of Medicine , Kutahya , Turkey.
Insights
Cardiac Syndrome X (CSX) is linked to a higher monocyte-to-HDL cholesterol ratio (MHR), an inflammation marker. This new marker may aid in predicting CSX, offering a cost-effective addition to existing methods.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- Cardiac Syndrome X (CSX) is characterized by angina-like chest pain and evidence of ischemia without coronary artery stenosis.
- Current diagnostic methods for CSX include exercise tests and myocardial perfusion scintigraphy.
- The role of inflammation in CSX pathogenesis is increasingly recognized.
Purpose of the Study:
- To investigate the association between Cardiac Syndrome X (CSX) and the monocyte-to-HDL cholesterol ratio (MHR).
- To evaluate MHR as a potential novel biomarker for CSX.
- To explore the relationship between MHR and other hematological parameters in CSX patients.
Main Methods:
- A study included 230 participants: 105 with CSX and 125 healthy controls.
- Peripheral venous blood samples were collected before coronary angiography.
- Monocyte-to-HDL cholesterol ratio (MHR) and other hematological parameters were measured.
Main Results:
- Patients with CSX exhibited significantly higher monocyte counts and MHR compared to controls.
- HDL-cholesterol levels were significantly lower in the CSX group.
- Elevated MHR and plateletcrit (PCT) were independently associated with the presence of CSX.
Conclusions:
- Elevated MHR is independently associated with the presence of Cardiac Syndrome X.
- MHR may serve as a valuable, cost-effective biomarker for CSX prediction.
- This finding suggests MHR can complement existing diagnostic approaches for CSX.
Objective:
Cardiac syndrome X (CSX) is typically identified with ischaemia in treadmill exercise test or stress myocardial perfusion scintigraphy as well as angina-like chest pain without stenosis in coronary angiography. The purpose of the present study is to investigate the association between cardiac syndrome X and monocyte-to-HDL cholesterol ratio (MHR) which is a new marker associated with inflammation.
Patients And Methods:
A total of 230 patients (105 patients with cardiac syndrome X and 125 normal controls) were included in the study. Peripheral venous blood samples were drawn from all study population before coronary angiography for measuring MHR and other haematological parameters.
Results:
The patients with cardiac syndrome X were more likely to have higher platelet counts, plateletcrit (PCT), monocyte count and MHR values. Monocyte count and MHR of the CSX group were significantly higher than the control group [0.53 (0.35-1) vs. 0.49 (0.23-0.96); p = .002, .011 (0.006-0.038) vs. 0.010 (0.004-0.034); p < .001, respectively]. HDL-cholesterol levels of the CSX group were significantly lower than the control groups (46.3 ± 10.1 vs. 49.6 ± 11.6; p = .021). Higher MHR and PCT values were found to be associated with the presence of CSX by multivariate logistic regression analysis.
Conclusions:
Elevated MHR level independently was found in association with the presence of CSX. The value of MHR appears additive to conventional expensive methods commonly used in CSX prediction.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
09:57Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Related Concept Videos
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures